Market Cap 47.09M
Revenue (ttm) 0.00
Net Income (ttm) -75.37M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio -0.38
Volume 1,705,300
Avg Vol 4,351,194
Day's Range N/A - N/A
Shares Out 44.42M
Stochastic %K 50%
Beta 0.56
Analysts Sell
Price Target $7.00

Company Profile

Outlook Therapeutics, Inc., operates as a clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic bevacizumab product formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-related macular degeneration and other retina diseases. Outlook Therapeutics, Inc. has collaboration agreements with Cencora. The company wa...

Industry: Biotechnology
Sector: Healthcare
Phone: 609 619 3990
Address:
111 S. Wood Avenue, Unit #100, Iselin, United States
PabloBuffet
PabloBuffet Oct. 5 at 2:30 AM
$OTLK Early accumulation is underway — not from big players yet, but from retail and small investors. The $0.90 area is the base, and $1.20 remains strong resistance. Larger institutions are likely to enter after upcoming catalysts such as earnings, an EU licensing partnership, and BLA resubmission, which together could break the $1.20 resistance and push the price toward $1.75. The most important near-term catalyst is securing an EU licensing partner. Why? Because once a deal is signed, OTLK receives immediate upfront cash, milestone payments, and royalties. This greatly reduces or even eliminates the company’s spending for EU operations, improving cash reserves and revenue growth. These developments could occur within the next three months, while the BLA resubmission, acceptance, and PDUFA decision (depending on review class) would likely extend the timeline by another six months from January 2026. This is not a suggestion or recommendation just my own interpretation and analysis.
0 · Reply
AnalystLLM
AnalystLLM Oct. 4 at 9:09 PM
$OTLK next week will be 6th week, the company pays by itself from revenue without any outside funding. each week it needs 1.2m and 6th week is 7.2m. If you wonder how it happens, the company needs 4.8m per month, July + August = 9.6m from (8.9m q3 cas left + 1.5m x 0.7 june revenue x gross margin)
0 · Reply
Consti22
Consti22 Oct. 4 at 2:48 PM
$OTLK We'll be taking off in the next 1-2 weeks. 😎💪
2 · Reply
IniG
IniG Oct. 4 at 12:49 PM
1 · Reply
Sam992009
Sam992009 Oct. 4 at 10:08 AM
0 · Reply
PhillyZ23
PhillyZ23 Oct. 4 at 1:16 AM
$OTLK is the company raising money? With all these stock option transactions?
1 · Reply
PhillyZ23
PhillyZ23 Oct. 3 at 11:11 PM
$OTLK https://www.sec.gov/Archives/edgar/data/1649989/000164998925000003/xslF345X05/primary_doc.xml
0 · Reply
Ihuarraqax123
Ihuarraqax123 Oct. 3 at 11:07 PM
$OTLK https://ir.outlooktherapeutics.com/static-files/81aee44d-1cb6-48a7-ba90-015f0394bb7a
0 · Reply
Jojototo
Jojototo Oct. 3 at 9:30 PM
$OTLK can someone explain how the algo work on sell and buy order on webull? it say there a huge sell order at 1.07 in webull but there was a huge bid earlier at 1.07 and it didnt track it?
1 · Reply
Britbox
Britbox Oct. 3 at 9:19 PM
$OTLK well my $1.05 buy order didn’t get filled, but there’s always next week
0 · Reply
Latest News on OTLK
Outlook Therapeutics Requests Type A Meeting with FDA

Sep 2, 2025, 8:35 AM EDT - 4 weeks ago

Outlook Therapeutics Requests Type A Meeting with FDA


FDA Rejects Outlook Therapeutics Eye Drug For Second Time

Aug 28, 2025, 11:15 AM EDT - 5 weeks ago

FDA Rejects Outlook Therapeutics Eye Drug For Second Time


Outlook Therapeutics Vision Loss Drug At Par With Novartis Drug

Jan 16, 2025, 12:09 PM EST - 9 months ago

Outlook Therapeutics Vision Loss Drug At Par With Novartis Drug

NVS


Top 3 Health Care Stocks That Could Blast Off This Month

Jan 6, 2025, 7:19 AM EST - 9 months ago

Top 3 Health Care Stocks That Could Blast Off This Month

INO RCKT


Outlook Therapeutics® Streamlines Operations

Dec 13, 2024, 4:30 PM EST - 10 months ago

Outlook Therapeutics® Streamlines Operations


Outlook Therapeutics® Announces Executive Leadership Transition

Dec 3, 2024, 4:30 PM EST - 10 months ago

Outlook Therapeutics® Announces Executive Leadership Transition


Outlook Therapeutics: Worth A Good Strong Look After CRL

Jun 13, 2024, 5:22 PM EDT - 1 year ago

Outlook Therapeutics: Worth A Good Strong Look After CRL


PabloBuffet
PabloBuffet Oct. 5 at 2:30 AM
$OTLK Early accumulation is underway — not from big players yet, but from retail and small investors. The $0.90 area is the base, and $1.20 remains strong resistance. Larger institutions are likely to enter after upcoming catalysts such as earnings, an EU licensing partnership, and BLA resubmission, which together could break the $1.20 resistance and push the price toward $1.75. The most important near-term catalyst is securing an EU licensing partner. Why? Because once a deal is signed, OTLK receives immediate upfront cash, milestone payments, and royalties. This greatly reduces or even eliminates the company’s spending for EU operations, improving cash reserves and revenue growth. These developments could occur within the next three months, while the BLA resubmission, acceptance, and PDUFA decision (depending on review class) would likely extend the timeline by another six months from January 2026. This is not a suggestion or recommendation just my own interpretation and analysis.
0 · Reply
AnalystLLM
AnalystLLM Oct. 4 at 9:09 PM
$OTLK next week will be 6th week, the company pays by itself from revenue without any outside funding. each week it needs 1.2m and 6th week is 7.2m. If you wonder how it happens, the company needs 4.8m per month, July + August = 9.6m from (8.9m q3 cas left + 1.5m x 0.7 june revenue x gross margin)
0 · Reply
Consti22
Consti22 Oct. 4 at 2:48 PM
$OTLK We'll be taking off in the next 1-2 weeks. 😎💪
2 · Reply
IniG
IniG Oct. 4 at 12:49 PM
1 · Reply
Sam992009
Sam992009 Oct. 4 at 10:08 AM
0 · Reply
PhillyZ23
PhillyZ23 Oct. 4 at 1:16 AM
$OTLK is the company raising money? With all these stock option transactions?
1 · Reply
PhillyZ23
PhillyZ23 Oct. 3 at 11:11 PM
$OTLK https://www.sec.gov/Archives/edgar/data/1649989/000164998925000003/xslF345X05/primary_doc.xml
0 · Reply
Ihuarraqax123
Ihuarraqax123 Oct. 3 at 11:07 PM
$OTLK https://ir.outlooktherapeutics.com/static-files/81aee44d-1cb6-48a7-ba90-015f0394bb7a
0 · Reply
Jojototo
Jojototo Oct. 3 at 9:30 PM
$OTLK can someone explain how the algo work on sell and buy order on webull? it say there a huge sell order at 1.07 in webull but there was a huge bid earlier at 1.07 and it didnt track it?
1 · Reply
Britbox
Britbox Oct. 3 at 9:19 PM
$OTLK well my $1.05 buy order didn’t get filled, but there’s always next week
0 · Reply
SteelerJon
SteelerJon Oct. 3 at 8:16 PM
$OTLK Well our predictions fell short…buy we got that killer news! Stay positive and enjoy the weekend 😎🏦🏦
1 · Reply
AnalystLLM
AnalystLLM Oct. 3 at 7:39 PM
$OTLK time to close loaned share account.
1 · Reply
IniG
IniG Oct. 3 at 6:09 PM
$OTLK 101 K shares
1 · Reply
Jojototo
Jojototo Oct. 3 at 6:08 PM
$OTLK i agree with this approach this would help them get additional funding if required they can atm it at $5-$6 for further operations hoping that happen by december finger cross
1 · Reply
AnalystLLM
AnalystLLM Oct. 3 at 6:07 PM
$OTLK are you kidding? cash flow is augumented day by day. From 8/28, it has been over 35 days, we do not need any dilution. the signal is getting clear
1 · Reply
IniG
IniG Oct. 3 at 6:00 PM
$OTLK "i doubt otlk will ever see $13 in my lifetime." Hmmm, thats so sad, you don'e even have 6 months more ... 😌
3 · Reply
IniG
IniG Oct. 3 at 5:56 PM
1 · Reply
Bennyman369
Bennyman369 Oct. 3 at 5:44 PM
$OTLK message to the board of directors : Give an update on sales and a good forecast for 2025-26. When the share price reaches $5-6, use the ATM to sell 5-6 million shares. It's that simple. A little dilution at a high price, everyone's happy. 😉
1 · Reply
AnalystLLM
AnalystLLM Oct. 3 at 5:39 PM
$OTLK every morning i only check one thing ”when the company need the money from bank”, apparently it has been 30 days no news and keep going. it means the lytenava business is getting better everyday
0 · Reply
Bennyman369
Bennyman369 Oct. 3 at 5:09 PM
$BURU Time to push $OTLK guys. Huge breakout is coming!!🌋🌋🌋
2 · Reply
Bennyman369
Bennyman369 Oct. 3 at 5:06 PM
0 · Reply
Bennyman369
Bennyman369 Oct. 3 at 5:05 PM
$OTLK We're almost there 👀👇
0 · Reply